Design Therapeutics, Inc. (DSGN) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts DSGN Hot Sheet
Join SI Premium – FREE
Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q1 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
